Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 4 subfamily D member 9 (OR4D9) is a member of the olfactory receptor gene family, which comprises a large group of genes encoding G protein-coupled receptors responsible for detecting odorant molecules in the nose, initiating a neuronal response that leads to odor perception[5][1][2]. Olfactory receptors are characterized by a seven-transmembrane domain structure and typically have a single coding exon[5][1][2]. While olfactory receptors as a class are involved in signal transduction by activating G proteins in response to odorant binding, OR4D9 specifically is listed as a pseudogene in some databases, indicating it may not produce a functional protein in humans[5][3]. No drugs are known to specifically target OR4D9, nor has it been established as a therapeutic target in any disease context[5][3].\n\nNote: This target is problematic because some databases (e.g., GeneCards, Ensembl) list it as a pseudogene, implying lack of protein-coding function in humans[5][3]. This disqualifies it as a classic therapeutic target and merits the flag in the is_incorrect field.\n\nSummary of key points\n- The canonical full name is “Olfactory receptor family 4 subfamily D member 9,” with “OR4D9” as the canonical abbreviation.\n- OR4D9 is classified under G protein-coupled receptors involved in olfactory signaling.\n- It is not a known therapeutic target, drug target, or disease biomarker, and no drugs are documented to interact with it.\n- It is likely a pseudogene in humans, so it is not functionally expressed as a protein[5][3].\n- The principal role of the gene family is odorant detection, but OR4D9 itself probably does not have a discernible physiological or disease-related function in humans[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily D member 9 (OR4D9).